Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1Phase 1 1

Status

Completed 6Terminated 4

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4Thoracic 1

Conditions

Colorectal Neoplasms 10Esophageal Neoplasms 4Neoplasms 3Urinary Bladder Neoplasms 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Rectal Neoplasms 1Ovarian Neoplasms 1Oesophago-gastric Cancer 1KRAS and NRAS Wild-type Colorectal Cancer 1Gliosarcoma 1Glioma 1Glioblastoma 1Fallopian Tube Neoplasms 1Esophageal Squamous Cell Carcinoma 1Cone Dystrophy 3 1Colorectal Cancer Metastatic 1Colonic Neoplasms 1Breast Neoplasms 1Advanced Colorectal Cancer 1Adenocarcinoma Of Esophagus 1Adenocarcinoma 1

Interventions

Fluorouracil 17Cisplatin 17pembrolizumab 12Radiotherapy 11Oxaliplatin 10Irinotecan 9Paclitaxel 6Leucovorin 6Docetaxel 6Carboplatin 6Capecitabine 6Neoadjuvant Therapy 5Trastuzumab 4Panitumumab 4Gefitinib 4Esophagectomy 4Cyclophosphamide 4Cetuximab 4Surgical Procedures, Operative 3Celecoxib 3tegafur-gimeracil-oteracil 2spartalizumab 2sodium glycididazole 2niraparib 2fludarabine 2S 1 (combination) 2Plicamycin 2Pemetrexed 2Lapatinib 2Gemcitabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × Esophageal Neoplasms × Panitumumab × Clear all
NCT01307956 2023-10-26

Panitumumab, Combination Chemotherapy, & Radiation Therapy in Esophageal or Gastroesophageal Junction Cancer

University of Nebraska

Phase 2 Terminated
11 enrolled 11 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT01128387 2019-12-09

Trial of Panitumumab/Cisplatin/Fluorouracil Combined With Radiation in Esophageal Cancer

University of Wisconsin, Madison

Phase 1/2 Terminated
11 enrolled 10 charts
Gastrointestinal

Esophageal Neoplasms, Neoplasms

NCT00101907 2014-03-20

Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced Cancer

Amgen

Phase 1 Terminated
41 enrolled 17 charts
GastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms, Pancreatic Neoplasms

NCT01262183 2012-05-11

PANORAMIC

Radboud University Medical Center

Phase 2 Terminated
4 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡